Development and Function of the Adult Generation of Leydig Cells in Mice with Sertoli Cell-Selective or Total Ablation of the Androgen Receptor

• DOI: 10.1210/en.2005-0300
• Publication Date: 2005-05-27T00:25:04Z
• Authors: Karel De Gendt; Nina Atanassova; Karen A. L. Tan; Luiz Renato de Fr...; Gleydes Gambogi P...; Chris McKinnell; Richard M. Sharpe; Philippa T. K. Sa...; J. Ian Mason; Stefan Hartung; Richard Ivell; Evi Denolet; Guido Verhoeven
• Keywords: Male; Mice, Knockout; Microscopy; 0303 health sciences; 571; Sertoli Cells; 572; Knockout; Age Factors; Leydig Cells; Cell Count; Inbred C57BL; Electron; Androgen; Mice, Inbred C57BL; Mice; Microscopy, Electron; 03 medical and health sciences; Receptors, Androgen; Receptors; Testis; Androgens; Animals; Female

AbstractIt is established that androgens and unidentified Sertoli cell (SC)-derived factors can influence the development of adult Leydig cells (LC) in rodents, but the mechanisms are unclear. We evaluated adult LC development and function in SC-selective androgen receptor (AR) knockout (SCARKO) and complete AR knockout (ARKO) mice. In controls, LC number increased 26-fold and LC size increased by approximately 2-fold between 12 and 140 d of age. LC number in SCARKOs was normal on d 12, but was reduced by more than 40% at later ages, although LC were larger and contained more lipid droplets and mitochondria than control LC by adulthood. ARKO LC number was reduced by up to 83% at all ages compared with controls, and LC size did not increase beyond d 12. Serum LH and testosterone levels and seminal vesicle weights were comparable in adult SCARKOs and controls, whereas LH levels were elevated 8-fold in ARKOs, although testosterone levels appeared normal. Immunohistochemistry and quantitative PCR for LC-specific markers indicated steroidogenic function per LC was probably increased in SCARKOs and reduced in ARKOs. In SCARKOs, insulin-like factor-3 and estrogen sulfotransferase (EST) mRNA expression were unchanged and increased 3-fold, respectively, compared with controls, whereas the expression of both was reduced more than 90% in ARKOs. Changes in EST expression, coupled with reduced platelet-derived growth factor-A expression, are potential causes of altered LC number and function in SCARKOs. These results show that loss of androgen action on SC has major consequences for LC development, and this could be mediated indirectly via platelet-derived growth factor-A and/or estrogens/EST.